Keyphrases
Inflammatory Bowel Disease
100%
Crohn's Disease
75%
Gallstones
50%
Gastroenteritis
50%
Ulcerative Colitis
50%
Colonoscopy
50%
Biliary Tract
50%
Hermansky-Pudlak Syndrome
50%
Spinal Cord Injury
50%
Motor Activity
50%
Serum Biomarkers
50%
Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)
50%
Stool Biomarker
50%
Hepatotoxicity
50%
Bile Duct
25%
Commons Syndrome
25%
United States
25%
Common Cause
25%
Dysplasia
25%
Gallbladder
25%
Diagnosis Management
25%
Surgical Technique
25%
Laparoscopic Cholecystectomy
25%
Prompt Diagnosis
25%
Outpatient Care
25%
Stool Markers
25%
Appropriate Management
25%
Inpatient Care
25%
Long-term Complications
25%
Rapid Resolution
25%
Endoscopic Technique
25%
Disease Behavior
25%
Proteomic Approach
25%
Prognosticate
25%
High-risk Individuals
25%
Disease Activity
25%
Novel Biomarkers
25%
Genomic Approaches
25%
Crohn's Colitis
20%
Bowel Evacuation
20%
Barium
20%
Evacuation
20%
Oatmeal
20%
Rectum
20%
Descending Colon
20%
Colonic Motility
20%
Co-infection
16%
Nevirapine
16%
Aspartate Aminotransferase
16%
Biopsy Specimen
12%
Medicine and Dentistry
Nonnucleoside Reverse Transcriptase Inhibitor
50%
Liver Toxicity
50%
Ocular Albinism
50%
Gallstone
50%
Diffuse Reflectance Spectroscopy
50%
Spinal Cord Injury
50%
Hepatobiliary System
50%
Enterocolitis
50%
Inflammatory Bowel Disease
50%
Motor Activity
50%
Colonoscopy
50%
Disease
50%
Hepatitis B Virus
40%
Dysplasia
33%
Bile Duct
25%
Laparoscopic Cholecystectomy
25%
Crohn's Disease
25%
Outpatient
25%
Aspartate Aminotransferase
20%
Mixed Infection
20%
Alanine Aminotransferase
20%
Nevirapine
20%
Evacuation
18%
Colon
16%
Chromoendoscopy
16%
Patient with Inflammatory Bowel Disease
16%
Terminal Ileum
16%
Colorectal Carcinoma
16%
Biopsy Technique
16%
Ceroid
12%
Human Immunodeficiency Virus
10%
Delavirdine
10%
Efavirenz
10%
Retrospective Study
10%
Hepatitis B
10%
Hepatitis C
10%
Hepatitis C Virus
10%
Peristalsis
9%
Descending Colon
9%
Colon Motility
9%
Scanning Electron Microscopy
9%
Combination Therapy
6%
Thrombocyte Dysfunction
6%
Bleeding Diathesis
6%
Colitis
6%
Tyrosinase
6%
Metronidazole
6%
Oculocutaneous Albinism
6%
Granulomatous Colitis
6%
Infliximab
6%
Pharmacology, Toxicology and Pharmaceutical Science
Crohn's Disease
75%
Ocular Albinism
50%
Inflammatory Bowel Disease
50%
Enterocolitis
50%
Ulcerative Colitis
50%
Nonnucleoside Reverse Transcriptase Inhibitor
50%
Hepatotoxicity
50%
Disease
40%
Hepatitis B Virus
40%
Nevirapine
20%
Mixed Infection
20%
Aspartate Aminotransferase
20%
Alanine Aminotransferase
20%
Combination Therapy
16%
Ceroid
12%
Colitis
12%
Hepatitis C
10%
Delavirdine
10%
Retrospective Study
10%
HIV
10%
Clinical Trial
10%
Efavirenz
10%
Intestine Flora
10%
Placebo
10%
Hepatitis B
10%
Hepatitis C Virus
10%
Infliximab
6%
Granulomatosis
6%
Syndrome
6%
Tyrosinase
6%
Oculocutaneous Albinism
6%
Thrombocyte Dysfunction
6%
Lipofuscin
6%
Bleeding Tendency
6%
Sulfasalazine
6%
Aminosalicylic Acid
6%
Metronidazole
6%
Autosomal Recessive Disorder
6%
